About Us

Focused on the R&D and commercialization of innovative medical devices for heart failure.

Brand Story

Dynaheart Medical has fully deployed mechanical circulatory support devices for heart failure, delivering comprehensive and multidimensional treatment solutions for patients.

Our product portfolio includes percutaneous ventricular assist devices, implantable ventricular assist devices, biventricular assist devices, and associated surgical instruments, as well as intra-aortic balloon pump catheters and consoles.

Comprehensive coverage of high-risk PCI, cardiogenic shock from various causes, acute heart failure, end-stage heart failure, and cardiorenal syndrome.

Through years of development, we have established a comprehensive R&D system and industrialization capabilities, holding multiple core patents. Our products are clinically used in hundreds of hospitals nationwide, saving countless lives.

Mission & Vision

Our Mission

Built on proprietary R&D, we continuously innovate heart failure treatment technologies to deliver comprehensive, safe, and effective mechanical circulatory support solutions—ensuring every heart failure patient receives high-quality care.

Our Vision

To become the global leader in heart failure treatment, advance mechanical circulatory support technology, build a comprehensive heart failure care ecosystem, and make outstanding contributions to human health.

History

2021

Company established; initial team assembled. pVAD (OmniHeart) functional prototype completed.

2022

Complete the factory and laboratory construction. Omnileart4.0 design finalized; type testing completed.

2023

Shanghai Specialized, Refined, Differential, and Innovative SME. OmniHeart 4.0 clinical trials initiated. OmniHeart product series finalized for submission.

2024

Completed Series A funding; partnered with multiple top-tier hospitals

2025

OmniHert 4.0 has completed registration clinical trials. The intra-aortic balloon pump catheter is about to receive Class III medical device registration certification from the National Medical Products Administration.

2026

Built a nationwide sales network serving over 100 hospitals

Honors & Certifications

Shanghai Minhang District Tech Emerging Enterprise

High-quality Biomedical Enterprises in Minhang District, Shanghai

VB-Link Future Medical Specialty Innovation Solutions Challenge – Cardiology, Third Prize

Specialized and New SMEs, Shanghai Municipal Commission of Economy and Information Technology

Looking forward to collaborating

Interested in our products or technology? Feel free to contact us anytime.

Contact Us